vs
PROVIDENT FINANCIAL SERVICES INC（PFS）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
Bio-Techne的季度营收约是PROVIDENT FINANCIAL SERVICES INC的1.3倍（$295.9M vs $225.2M），PROVIDENT FINANCIAL SERVICES INC净利率更高（35.3% vs 12.8%，领先22.4%），过去两年PROVIDENT FINANCIAL SERVICES INC的营收复合增速更高（17.3% vs 4.2%）
PNC金融服务集团是总部位于美国宾夕法尼亚州匹兹堡的银行控股及金融服务企业，旗下银行子公司PNC银行业务覆盖美国27个州和华盛顿特区，拥有2629家营业网点与9523台ATM机，是美国资产规模、网点数量、存款规模、ATM保有量均位居前列的大型银行机构。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
PFS vs TECH — 直观对比
营收规模更大
TECH
是对方的1.3倍
$225.2M
净利率更高
PFS
高出22.4%
12.8%
两年增速更快
PFS
近两年复合增速
4.2%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $225.2M | $295.9M |
| 净利润 | $79.4M | $38.0M |
| 毛利率 | — | 64.6% |
| 营业利润率 | — | 18.4% |
| 净利率 | 35.3% | 12.8% |
| 营收同比 | — | -6.4% |
| 净利润同比 | 24.0% | 68.3% |
| 每股收益（稀释后） | $0.61 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PFSTECH
| Q1 26 | $225.2M | — | ||
| Q4 25 | $225.7M | $295.9M | ||
| Q3 25 | $221.8M | — | ||
| Q2 25 | $214.2M | $317.0M | ||
| Q1 25 | $208.8M | $316.2M | ||
| Q4 24 | $205.9M | $297.0M | ||
| Q3 24 | $210.6M | $289.5M | ||
| Q2 24 | $163.8M | $306.1M |
净利润PFSTECH
| Q1 26 | $79.4M | — | ||
| Q4 25 | — | $38.0M | ||
| Q3 25 | $71.7M | — | ||
| Q2 25 | $72.0M | $-17.7M | ||
| Q1 25 | $64.0M | $22.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | $46.4M | $33.6M | ||
| Q2 24 | $-11.5M | $40.6M |
毛利率PFSTECH
| Q1 26 | — | — | ||
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% |
营业利润率PFSTECH
| Q1 26 | — | — | ||
| Q4 25 | 49.7% | 18.4% | ||
| Q3 25 | 45.8% | — | ||
| Q2 25 | 47.8% | -7.5% | ||
| Q1 25 | 44.0% | 12.2% | ||
| Q4 24 | 30.5% | 16.0% | ||
| Q3 24 | 31.0% | 13.8% | ||
| Q2 24 | -13.0% | 15.0% |
净利率PFSTECH
| Q1 26 | 35.3% | — | ||
| Q4 25 | — | 12.8% | ||
| Q3 25 | 32.3% | — | ||
| Q2 25 | 33.6% | -5.6% | ||
| Q1 25 | 30.7% | 7.1% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | 22.0% | 11.6% | ||
| Q2 24 | -7.0% | 13.3% |
每股收益（稀释后）PFSTECH
| Q1 26 | $0.61 | — | ||
| Q4 25 | $0.64 | $0.24 | ||
| Q3 25 | $0.55 | — | ||
| Q2 25 | $0.55 | $-0.11 | ||
| Q1 25 | $0.49 | $0.14 | ||
| Q4 24 | $0.37 | $0.22 | ||
| Q3 24 | $0.36 | $0.21 | ||
| Q2 24 | $-0.11 | $0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $222.1M | $172.9M |
| 总债务越低越好 | — | $260.0M |
| 股东权益账面价值 | $2.9B | $2.0B |
| 总资产 | $25.2B | $2.5B |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资PFSTECH
| Q1 26 | $222.1M | — | ||
| Q4 25 | $209.1M | $172.9M | ||
| Q3 25 | $299.2M | — | ||
| Q2 25 | $258.0M | $162.2M | ||
| Q1 25 | $234.1M | $140.7M | ||
| Q4 24 | $205.9M | $177.5M | ||
| Q3 24 | $244.0M | $187.5M | ||
| Q2 24 | $290.5M | $152.9M |
总债务PFSTECH
| Q1 26 | — | — | ||
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M |
股东权益PFSTECH
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.8B | $2.0B | ||
| Q3 25 | $2.8B | — | ||
| Q2 25 | $2.7B | $1.9B | ||
| Q1 25 | $2.7B | $2.0B | ||
| Q4 24 | $2.6B | $2.1B | ||
| Q3 24 | $2.6B | $2.1B | ||
| Q2 24 | $2.6B | $2.1B |
总资产PFSTECH
| Q1 26 | $25.2B | — | ||
| Q4 25 | $25.0B | $2.5B | ||
| Q3 25 | $24.8B | — | ||
| Q2 25 | $24.5B | $2.6B | ||
| Q1 25 | $24.2B | $2.6B | ||
| Q4 24 | $24.1B | $2.7B | ||
| Q3 24 | $24.0B | $2.7B | ||
| Q2 24 | $24.1B | $2.7B |
负债/权益比PFSTECH
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PFS
| Net Interest Income | $193.7M | 86% |
| Noninterest Income | $31.5M | 14% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
